Characteristic | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|
HR | 95%CI | P* | HR | 95%CI | P** | ||
Gender | Female | Ref | Â | Â | Ref | Â | Â |
Male | 1.393 | 1.131–1.717 | 0.002 | 1.18 | 0.947–1.472 | 0.139 | |
Age | <65 | Ref | Â | Â | Ref | Â | Â |
65 | 1.300 | 1.059–1.596 | 0.012 | 1.497 | 1.177–1.904 | 0.001 | |
Race | Black | Ref | Â | Â | Ref | Â | Â |
White | 0.825 | 0.498–1.367 | 0.456 | 0.895 | 0.501–1.598 | 0.707 | |
Others | 0.761 | 0.438–1.323 | 0.333 | 0.738 | 0.399–1.367 | 0.331 | |
Surgery | No | Ref | Â | Â | Ref | Â | Â |
Yes | 0.629 | 0.466–0.847 | 0.002 | 0.544 | 0.391–0.758 | < 0.001 | |
Radiotherapy | No | Ref | Â | Â | Ref | Â | Â |
 | Yes | 1.289 | 1.018–1.539 | 0.04 | 0.489 | 0.342–0.713 | < 0.001 |
Chemotherapy | No | Ref | Â | Â | Ref | Â | Â |
 | Yes | 0.284 | 0.225–0.359 | < 0.001 | 0.191 | 0.146–0.250 | < 0.001 |
T stage | T1 | Ref | Â | Â | Ref | Â | Â |
T2 | 1.021 | 0.767–1.274 | 0.418 | 1.130 | 0.861–1.480 | 0.373 | |
T3 | 1.272 | 1.109–1.653 | 0.046 | 1.558 | 1.112–2.185 | 0.009 | |
T4 | 1.486 | 1.192–1.814 | 0.012 | 2.119 | 1.255–3.577 | 0.004 | |
LN metastasis | Absent | Ref | Â | Â | Ref | Â | Â |
Present | 1.318 | 1.010–1.519 | 0.028 | 1.253 | 0.798–0.964 | 0.047 | |
Bone Metastasis | Absent | Ref | Â | Â | Ref | Â | Â |
Present | 1.287 | 1.479–1.841 | 0.041 | 1.440 | 1.016–2.041 | 0.040 | |
Liver Metastasis | Absent | Ref | Â | Â | Ref | Â | Â |
Present | 1.254 | 0.993–1.583 | 0.058 | 1.255 | 0.899–1.752 | 0.183 | |
Lung Metastasis | Absent | Ref | Â | Â | Ref | Â | Â |
Present | 1.533 | 1.210–1.943 | < 0.001 | 1.247 | 0.905–1.718 | 0.177 | |
Grade | I + II | Ref |  |  | Ref |  |  |
III + IV | 1.314 | 1.018–1.671 | 0.045 | 1.289 | 1.033–1.609 | 0.025 | |
Tumor size | ≤ 5 cm | Ref |  |  | Ref |  |  |
>5 cm | 1.198 | 0.927–1.548 | 0.168 | 1.138 | 0.839–1.545 | 0.406 |